hcc
Conditions
Interventions
Sponsors
Beijing You'an Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Subjects who meet the following criteria can be included in this study: 1. Gender, age 18-70 (inclusive); 2. HCC meets the clinical diagnostic criteria of AASLD or EASL; 3. Subjects were not willing to have surgical excision; 4. BCLC medium liver cancer, the tumor number is less than 5, the maximum diameter is less than 10cm; 5. Good liver reserve function (child-pugh A level); 6. The ECOG score is 0.
Exclusion criteria
Exclusion criteria: 1. Waiting for surgical resection or liver transplantation; 2. The visible portal vein, hepatic vein, bile duct invasion; 3. Extrahepatic metastasis; 4. History of liver cancer treatment (transplantation, excision, TACE, ablation, radiotherapy); 5. Uncorrected clotting disorder (platelet count 50 x 109 / L or thrombin activity 176.8 mu mol/L); 12. AST and/or ALT >3 times normal limit; 13. Pregnant or lactating subjects, women of childbearing age must receive a serum pregnancy test within 72 hours of the start of treatment; 14. Allergy to known iodine contrast agents;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CT; | — |
Countries
China
Contacts
Public ContactZheng Jiasheng; Zhang Yonghong
Beijing You'an Hospital, Capital Medical University
Outcome results
None listed